HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Roberto Ferrari Selected Research

Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

12/2015Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
6/2014Coronary artery disease: Use of ACE inhibitors in stable CAD--what is the truth?
6/2013The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.
1/2013RAAS inhibition and mortality in hypertension.
6/2011ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes.
3/2011A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals.
8/2010Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
8/2010Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
7/2008Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy.
12/2007Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Roberto Ferrari Research Topics

Disease

58Myocardial Infarction
12/2015 - 04/2002
52Heart Failure
12/2015 - 11/2002
47Coronary Artery Disease (Coronary Atherosclerosis)
12/2015 - 06/2004
15Thrombosis (Thrombus)
06/2013 - 11/2005
13Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 03/2002
12Hypertension (High Blood Pressure)
08/2015 - 01/2005
10Coronary Disease (Coronary Heart Disease)
10/2015 - 07/2005
8Stroke (Strokes)
07/2013 - 01/2005
7Heart Arrest (Cardiac Arrest)
12/2015 - 04/2007
7Ischemia
12/2015 - 07/2002
7Left Ventricular Dysfunction
10/2015 - 01/2004
7Hemorrhage
02/2014 - 10/2010
6Acute Coronary Syndrome
08/2013 - 07/2004
5Neoplasms (Cancer)
11/2014 - 05/2009
5Inflammation
08/2013 - 03/2002
5Necrosis
07/2011 - 01/2004
5Vascular Diseases (Vascular Disease)
03/2011 - 01/2005
4Atrial Fibrillation
12/2015 - 08/2009
4Ventricular Remodeling
01/2011 - 11/2004
3Chronic Obstructive Pulmonary Disease (COPD)
12/2015 - 01/2013
3Diabetes Mellitus
07/2015 - 07/2013
3Hypertrophy
07/2015 - 01/2004
3Atherosclerosis
03/2015 - 05/2009
3Infection
11/2014 - 07/2012
3Hyperplasia
02/2014 - 11/2010
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2012 - 12/2003
2Bradycardia
12/2015 - 09/2014
2Systolic Heart Failure
10/2015 - 06/2009
2Cicatrix (Scar)
07/2013 - 06/2009
2Infarction
06/2013 - 01/2007
2Retinoblastoma (Glioblastoma, Retinal)
07/2012 - 08/2008
2Septic Shock (Toxic Shock Syndrome)
05/2005 - 05/2003
1Drug Toxicity (Drug Safety)
12/2015
1Mitral Valve Insufficiency (Mitral Regurgitation)
12/2015
1Obesity
08/2015
1Type 2 Diabetes Mellitus (MODY)
03/2015
1Albuminuria
03/2015
1Glucosephosphate Dehydrogenase Deficiency
01/2015

Drug/Important Bio-Agent (IBA)

29PerindoprilFDA LinkGeneric
12/2015 - 01/2005
18Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2013 - 03/2002
17Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2015 - 12/2004
13ivabradineIBA
12/2015 - 05/2006
13tirofiban (Aggrastat)FDA Link
04/2013 - 05/2004
10Sirolimus (Rapamycin)FDA Link
04/2013 - 05/2004
10clopidogrel (Plavix)FDA Link
04/2012 - 08/2008
9Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2015 - 06/2004
9abciximab (ReoPro)FDA Link
04/2013 - 05/2004
7glucuronyl glucosamine glycan sulfate (Vessel)IBA
03/2014 - 07/2004
6bipiperidyl mustard (BPM)IBA
09/2014 - 09/2008
5Glucose (Dextrose)FDA LinkGeneric
08/2015 - 04/2002
5CytokinesIBA
01/2014 - 02/2005
4BradykininIBA
03/2011 - 11/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2009 - 01/2004
4Glycoproteins (Glycoprotein)IBA
08/2008 - 07/2004
3Carbon MonoxideIBA
12/2015 - 09/2006
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2015 - 03/2013
3ProdigyIBA
02/2014 - 11/2010
3Histones (Histone)IBA
02/2014 - 08/2008
3Angiotensin Receptor AntagonistsIBA
06/2013 - 06/2011
3AdenosineFDA LinkGeneric
06/2013 - 01/2007
3OxygenIBA
01/2013 - 01/2004
3thienopyridineIBA
10/2010 - 07/2007
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2004 - 03/2002
2Factor XIII (Coagulation Factor XIII)IBA
07/2015 - 01/2007
2acteosideIBA
07/2015 - 10/2012
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2015 - 06/2009
2AnticoagulantsIBA
01/2015 - 12/2012
2CholesterolIBA
07/2013 - 04/2006
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
06/2013 - 07/2009
2erucylphosphocholineIBA
01/2013 - 09/2004
2Proteins (Proteins, Gene)IBA
07/2012 - 08/2008
2valsartan (Vals)FDA Link
06/2011 - 11/2003
2TNF-Related Apoptosis-Inducing LigandIBA
07/2010 - 05/2010
2Calcium Channels (Calcium Channel)IBA
05/2010 - 12/2008
2Ramipril (Altace)FDA LinkGeneric
07/2009 - 09/2006
2Biological Markers (Surrogate Marker)IBA
05/2009 - 11/2005
2Factor VII (Proconvertin)IBA
02/2009 - 12/2006
2Angiotensin IIIBA
01/2009 - 03/2002
2Platelet Membrane Glycoprotein IIbIBA
12/2006 - 07/2004
2trandolapril (Mavik)FDA LinkGeneric
09/2006 - 01/2004
2nebivololFDA Link
02/2005 - 11/2002
2Carnitine (L-Carnitine)FDA LinkGeneric
11/2004 - 02/2004
2MonocrotalineIBA
01/2004 - 03/2003
1LDL CholesterolIBA
08/2015
1TroponinIBA
07/2015
1Natriuretic PeptidesIBA
07/2015
1Uric Acid (Urate)IBA
03/2015
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2015
1Lysine (L-Lysine)FDA Link
11/2014
1ChromatinIBA
11/2014
1AcetylesteraseIBA
11/2014

Therapy/Procedure

19Stents
02/2014 - 05/2004
7Cardiac Resynchronization Therapy
07/2013 - 05/2006
2Drug Therapy (Chemotherapy)
01/2014 - 07/2008
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2013 - 11/2004
2Ligation
01/2011 - 01/2006
2Catheters
08/2009 - 08/2006
2Angioplasty (Angioplasty, Transluminal)
06/2009 - 04/2008
1Inappropriate Prescribing
12/2015
1Drug-Eluting Stents
01/2015